Share Data

At Anavex Life Sciences, we strive to produce sustained strong performance and shareholder value.

NASDAQ: AVXL

Key Data

Industry

Biopharmaceutical

Sector

New drug discovery

Fiscal year end

September 30

Shares issued and outstanding

76,018,053 *

Stock purchase warrants

210,000 **

Stock options

11,330,903 **

Fully diluted

87,459,368**

Cash

$152.1 million **

Debt

Nil **

Trading symbol

AVXL

52-week range

$31.50 - $3.65 *

Financial statements and filings

Anavex's filings can be found on EDGAR

Investor relations

Transfer agent

Nevada Agency and Trust

 

50 West Liberty Street,

Suite 880

Reno, Nevada 89501

Tel:  (775) 322-0626

Fax: (775) 322-5623

email: info@natco.org

Resident Agent

email: corpserve@natco.org

Website: www.natco.org

*   As at November 19, 2021

** As at September 30, 2021

Forms - Reverse Stock Split

Internal Revenue Service (United States) - Form 8937